Edesa Biotech, Inc.
Cultured post-larval giant keyhole clams (Megathura crenulata) for harvesting Crassocollin, a novel bioactive molecule
- Sector
- Biotech
- Headquarters
- MARKHAM, A6
- Founded
- 2007
- Latest Form D
- $3.5M, Jun 2026
- Total capital
- $28.6M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $28.4M
- 8 Form D · last Jun 2026
- 4 months since last filing
- Federal contracts
- $214K
- 3 awards · Health and Human S
- Rank in Biotech#290 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$3.5M
- Private capital raisedForm D · SEC · 6th filing$15M
- Federal contractHealth and Human S · Igf::ot::igf Cgmp Klh Purchase, Vialing And Stability Testing For 3 Clinical Trials$193K
- Private capital raisedForm D · SEC · 5th filing$6.8M
- Offering registeredForm D · SEC · 4th filing$12M
- Private capital raisedForm D · SEC · 3rd filing$1.6M
- Private capital raisedForm D · SEC · 2nd filing$505K
- Private capital raisedForm D · SEC · 1st filing$1M
Show 1 earlier federal award
- Federal contractHealth and Human S · Keyhole Limpet Hemocyanin$21K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
2 records have no date or no amount, so they aren’t placed on the timeline.
Federal first
33months
from Edesa Biotech, Inc.’s first federal award to its first private round.
- First federal award · Feb 2010
- Health and Human S · $21K
- First Form D · Oct 2012
- $1M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Carlo SistilliDirectorNamed in SEC Form D filings
- Charles OlsonDirectorNamed in SEC Form D filings
- David LiuDirectorNamed in SEC Form D filings
- Frank OakesDirectorNamed in SEC Form D filings
- Joan ChypyhaDirectorNamed in SEC Form D filings
- Michael BrooksExecutive OfficerNamed in SEC Form D filings
Show all 11 people
- Pardeep NijhawanExecutive Officer, DirectorNamed in SEC Form D filings
- Patrick MarshallDirectorNamed in SEC Form D filings
- Peter WeilerExecutive OfficerNamed in SEC Form D filings
- Sean MacDonaldDirectorNamed in SEC Form D filings
- Stephen LemieuxExecutive OfficerNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Global Blood TherapeuticsSimilar federal contract value in Biotech · $219K in contracts
- THERMOGENESIS CORP.Similar federal contract value in Biotech · $218K in contracts
- ZoneOne PharmaSimilar federal contract value in Biotech · $216K in contracts
- THE TINY CARGO COMPANYSimilar federal contract value in Biotech · $210K in contracts
- Ursa AnalyticsSimilar federal contract value in Biotech · $205K in contracts
- Avidity BiosciencesSimilar federal contract value in Biotech · $200K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .